Hepatology 55 1154 -1163 2012. doi.Thaiss CA Itav S Rothschild D Meijer M Levy M Moresi C Dohnalova L Braverman S Rozin S Malitsky S Dori-Bachash M Kuperman Y Biton I Gertler A Harmelin A Shapiro H Halpern Z Aharoni A Segal E Elinav E. Persistent microbiome alterations mod- ulate the rate of post-dieting weight regain.

Transpl Infect Dis 17 174 -184 2015. doi.Grat M Wronka KM Krasnodebski M Masior L Lewandowski Z Kosinska I Grat K Stypulkowski J Rejowski S Wasilewicz M Galecka M Szachta P Krawczyk M. Profile of gut microbiota associated with the presence of hepatocellular cancer in patients with liver cirrhosis.

Hepatology 39 484 -491 2004. doi.Frost G Sleeth ML Sahuri-Arisoylu M Lizarbe B Cerdan S Brody L Anastasovska J Ghourab S Hankir M Zhang S Carling D Swann JR Gibson G Viardot A Morrison D Louise Thomas E Bell JD.

Nature 540 544 -551 2016. doi.Thuy S Ladurner R Volynets V Wagner S Strahl S Konigsrainer A Maier KP Bischoff SC Bergheim I. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasmin-MICROBIOME NAFLD AND LIFESTYLE MODIFICATION399ogen activator inhibitor 1 concentrations and with fructose intake.

Am J Gastroenterol 84 1027-1033 1989.Wos-Oxley M Bleich A Oxley AP Kahl S Janus LM Smoczek A Nahrstedt H Pils MC Taudien S Platzer M Hedrich HJ Medina E Pieper DH.

Clin Gastroenterol Hepatol 14 1619 -1628 2016. doi.Grat M Holowko W Wronka KM Grat K Lewandowski Z Kosinska I Krasnodebski M Wasilewicz M Galecka M Szachta P Zborowska H Patkowski W Krawczyk M. The relevance of intestinal dysbiosis in liver transplant candidates.

Food Funct 6 492-500 2015. doi.Lelouvier B Servant F Paisse S Brunet AC Benyahya S Serino M Valle C Ortiz MR Puig J Courtney M Federici M Fernandez-Real JM Burcelin R Amar J.

Curr Biol 17 R877-R878 2007. doi.Yoshimoto S Loo TM Atarashi K Kanda H Sato S Oyadomari S Iwakura Y Oshima K Morita H Hattori M Honda K Ishikawa Y Hara E Ohtani N. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome.

Oral Microbiol Immunol 23 348 -351 2008. doi.Malaguarnera M Vacante M Antic T Giordano M Chisari G Acquaviva R Mastrojeni S Malaguarnera G Mistretta A Li Volti G Galvano F. Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis.

Hepatology 50 1094 -1104 2009. doi.Stanhope KL Schwarz JM Keim NL Griffen SC Bremer AA Graham JL Hatcher B Cox CL Dyachenko A Zhang W McGahan JP Seibert A Krauss RM Chiu S Schaefer EJ Ai M Otokozawa S Nakajima K Nakano T Beysen C Hellerstein MK Berglund L Havel PJ.

